Evidence map›Paper›PMID 27600277›Full record

ArticleDiabetologia2016

Interaction between the obesity-risk gene FTO and the dopamine D2 receptor gene ANKK1/TaqIA on insulin sensitivity.

Martin Heni, Stephanie Kullmann, Emma Ahlqvist, Robert Wagner, Fausto Machicao, Harald Staiger, Hans-Ulrich Häring, Peter Almgren, Leif C Groop, Dana M Small and 2 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Diabetologia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Prenatal Effects of Nicotine on Obesity Risks: A Narrative Review.International journal of environmental research and public health · 2022
    Review
  7. Review
  8. Emerging Roles of FTO in Neuropsychiatric Disorders.BioMed research international · 2022
    Review
  9. Article
  10. Low-Density Lipoprotein Cholesterol Is Associated With Insulin Secretion.The Journal of clinical endocrinology and metabolism · 2021
    Article
  11. Article
  12. Dopaminergic Pathways in Obesity-Associated Inflammation.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2020
    Review
  13. Interactions betweenNutrients · 2019
    Article
  14. Role of RNA modifications in brain and behavior.Genes, brain, and behavior · 2018
    Review
  15. FTO genotype impacts food intake and corticolimbic activation.The American journal of clinical nutrition · 2018
    Observational
  16. Article
  17. Article
  18. Review
  19. Article
  20. DRD2: Bridging the Genome and Ingestive Behavior.Trends in cognitive sciences · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Martin HeniDepartment of Internal Medicine, Division of Endocrinology, Diabetology, Angiology, Nephrology and Clinical Chemistry, Eberhard Karls University Tübingen, Tübingen, Germany.
Stephanie KullmannInstitute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Otfried-Müller-Straße 47, 72076, Tübingen, Germany. stephanie.kullmann@med.uni-tuebingen.de.
Emma AhlqvistLund University Diabetes Centre, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Robert WagnerDepartment of Internal Medicine, Division of Endocrinology, Diabetology, Angiology, Nephrology and Clinical Chemistry, Eberhard Karls University Tübingen, Tübingen, Germany.
Fausto MachicaoInstitute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Otfried-Müller-Straße 47, 72076, Tübingen, Germany.
Harald StaigerInstitute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Otfried-Müller-Straße 47, 72076, Tübingen, Germany.
Hans-Ulrich HäringDepartment of Internal Medicine, Division of Endocrinology, Diabetology, Angiology, Nephrology and Clinical Chemistry, Eberhard Karls University Tübingen, Tübingen, Germany.
Peter AlmgrenLund University Diabetes Centre, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Leif C GroopLund University Diabetes Centre, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Dana M SmallDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Andreas FritscheDepartment of Internal Medicine, Division of Endocrinology, Diabetology, Angiology, Nephrology and Clinical Chemistry, Eberhard Karls University Tübingen, Tübingen, Germany.
Hubert PreisslDepartment of Internal Medicine, Division of Endocrinology, Diabetology, Angiology, Nephrology and Clinical Chemistry, Eberhard Karls University Tübingen, Tübingen, Germany.
Heinrich Heine University Düsseldorf · DEGerman Center for Diabetes Research · DELund University · SEUniversity of Helsinki · FIUniversity of Tübingen · DEYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisVariations in FTO are the strongest common genetic determinants of adiposity, and may partly act by influencing dopaminergic signalling in the brain leading to altered reward processing that promotes increased food intake. Therefore, we investigated the impact of such an interaction on body composition, and peripheral and brain insulin sensitivity.

methodsParticipants from the Tübingen Family study (n = 2245) and the Malmö Diet and Cancer study (n = 2921) were genotyped for FTO SNP rs8050136 and ANKK1 SNP rs1800497. Insulin sensitivity in the caudate nucleus, an important reward area in the brain, was assessed by fMRI in 45 participants combined with intranasal insulin administration.

resultsWe found evidence of an interaction between variations in FTO and an ANKK1 polymorphism that associates with dopamine (D2) receptor density. In cases of reduced D2 receptor availability, as indicated by the ANKK1 polymorphism, FTO variation was associated with increased body fat and waist circumference and reduced peripheral insulin sensitivity. Similarly, altered central insulin sensitivity was observed in the caudate nucleus in individuals with the FTO obesity-risk allele and diminished D2 receptors. CONCLUSIONS/

interpretationThe effects of variations in FTO are dependent on dopamine D2 receptor density (determined by the ANKK1 polymorphism). Carriers of both risk alleles might, therefore, be at increased risk of obesity and diabetes.

Indexed as

Adipose TissueAdministration, IntranasalAdultAlpha-Ketoglutarate-Dependent Dioxygenase FTOFemaleGenetic Predisposition to DiseaseGenotypeGlucose Tolerance TestHumansInsulinInsulin ResistanceMagnetic Resonance SpectroscopyMaleMiddle AgedObesityPolymorphism, Single NucleotideAlpha-Ketoglutarate-Dependent Dioxygenase FTOANKK1 protein, humanDRD2 protein, humanFTO protein, humanInsulinProtein Serine-Threonine KinasesReceptors, Dopamine D2ANKK1Body fatDopamineFTOInsulin sensitivityTaqIA

Identifiers

PMID27600277
OpenAlexW2516759441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.